Literature DB >> 26648042

Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice.

Carmen Capone1,2, Emmanuel Cognat1,2, Lamia Ghezali1,2, Céline Baron-Menguy1,2, Déborah Aubin1,2, Laurent Mesnard3,4, Heidi Stöhr5, Valérie Domenga-Denier1,2, Mark T Nelson6,7, Anne Joutel1,2.   

Abstract

OBJECTIVE: CADASIL is a genetic paradigm of cerebral small vessel disease caused by NOTCH3 mutations that stereotypically lead to the extracellular deposition of NOTCH3 ectodomain (Notch3(ECD) ) on the vessels. TIMP3 and vitronectin are 2 extracellular matrix proteins that abnormally accumulate in Notch3(ECD) -containing deposits on brain vessels of mice and patients with CADASIL. Herein, we investigated whether increased levels of TIMP3 and vitronectin are responsible for aspects of CADASIL disease phenotypes.
METHODS: Timp3 and vitronectin expression were genetically reduced in TgNotch3(R169C) mice, a well-established preclinical model of CADASIL. A mouse overexpressing human TIMP3 (TgBAC-TIMP3) was developed. Disease-related phenotypes, including cerebral blood flow (CBF) deficits, white matter lesions, and Notch3(ECD) deposition, were evaluated between 6 and 20 months of age.
RESULTS: CBF responses to neural activity (functional hyperemia), topical application of vasodilators, and decreases in blood pressure (CBF autoregulation) were similarly reduced in TgNotch3(R169C) and TgBAC-TIMP3 mice, and myogenic responses of brain arteries were likewise attenuated. These defects were rescued in TgNotch3(R169C) mice by haploinsufficiency of Timp3, although the number of white matter lesions was unaffected. In contrast, haploinsufficiency or loss of vitronectin in TgNotch3(R169C) mice ameliorated white matter lesions, although CBF responses were unchanged. Amelioration of cerebrovascular reactivity or white matter lesions in these mice was not associated with reduced Notch3(ECD) deposition in brain vessels.
INTERPRETATION: Elevated levels of TIMP3 and vitronectin, acting downstream of Notch3(ECD) deposition, play a role in CADASIL, producing divergent influences on early CBF deficits and later white matter lesions.
© 2016 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26648042      PMCID: PMC5359978          DOI: 10.1002/ana.24573

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

Review 1.  Notch signalling in smooth muscle cells during development and disease.

Authors:  Charles Fouillade; Marie Monet-Leprêtre; Céline Baron-Menguy; Anne Joutel
Journal:  Cardiovasc Res       Date:  2012-01-19       Impact factor: 10.787

Review 2.  ADAMs: key components in EGFR signalling and development.

Authors:  Carl P Blobel
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

Review 3.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

Review 4.  Vitronectin in vascular context: facets of a multitalented matricellular protein.

Authors:  Klaus T Preissner; Ute Reuning
Journal:  Semin Thromb Hemost       Date:  2011-07-30       Impact factor: 4.180

5.  Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension.

Authors:  Carmen Capone; Giuseppe Faraco; Jeffrey R Peterson; Christal Coleman; Josef Anrather; Teresa A Milner; Virginia M Pickel; Robin L Davisson; Costantino Iadecola
Journal:  J Neurosci       Date:  2012-04-04       Impact factor: 6.167

6.  Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3.

Authors:  Andreas Janssen; Julia Hoellenriegel; Marton Fogarasi; Heinrich Schrewe; Mathias Seeliger; Ernst Tamm; Andreas Ohlmann; Christian Albrecht May; Bernhard H F Weber; Heidi Stöhr
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

7.  Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein.

Authors:  Kiyoshi Niwa; Ken Kazama; Linda Younkin; Steven G Younkin; George A Carlson; Costantino Iadecola
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

8.  The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells.

Authors:  Richard Daneman; Lu Zhou; Dritan Agalliu; John D Cahoy; Amit Kaushal; Ben A Barres
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

9.  Polyglutamine protein aggregates are dynamic.

Authors:  Soojin Kim; Ellen A A Nollen; Kazunori Kitagawa; Vytautas P Bindokas; Richard I Morimoto
Journal:  Nat Cell Biol       Date:  2002-10       Impact factor: 28.213

10.  Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model.

Authors:  Emmanuel Cognat; Sabine Cleophax; Valérie Domenga-Denier; Anne Joutel
Journal:  Acta Neuropathol Commun       Date:  2014-04-30       Impact factor: 7.801

View more
  31 in total

Review 1.  The pericyte microenvironment during vascular development.

Authors:  Laura B Payne; Huaning Zhao; Carissa C James; Jordan Darden; David McGuire; Sarah Taylor; James W Smyth; John C Chappell
Journal:  Microcirculation       Date:  2019-05-27       Impact factor: 2.628

Review 2.  Contributions of Aging to Cerebral Small Vessel Disease.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Annu Rev Physiol       Date:  2019-10-16       Impact factor: 19.318

3.  Neurovascular coupling during optogenetic functional activation: Local and remote stimulus-response characteristics, and uncoupling by spreading depression.

Authors:  Maximilian Böhm; David Y Chung; Carlos A Gómez; Tao Qin; Tsubasa Takizawa; Homa Sadeghian; Kazutaka Sugimoto; Sava Sakadžić; Mohammad A Yaseen; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2019-05-07       Impact factor: 6.200

4.  Increased Notch3 Activity Mediates Pathological Changes in Structure of Cerebral Arteries.

Authors:  Celine Baron-Menguy; Valérie Domenga-Denier; Lamia Ghezali; Frank M Faraci; Anne Joutel
Journal:  Hypertension       Date:  2016-11-07       Impact factor: 10.190

Review 5.  Perivascular spaces, glymphatic dysfunction, and small vessel disease.

Authors:  Humberto Mestre; Serhii Kostrikov; Rupal I Mehta; Maiken Nedergaard
Journal:  Clin Sci (Lond)       Date:  2017-08-10       Impact factor: 6.124

Review 6.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

7.  HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.

Authors:  Jackson T Fontaine; Amanda C Rosehart; Anne Joutel; Fabrice Dabertrand
Journal:  Mech Ageing Dev       Date:  2020-10-27       Impact factor: 5.432

Review 8.  Notch3 Signaling and Aggregation as Targets for the Treatment of CADASIL and Other NOTCH3-Associated Small-Vessel Diseases.

Authors:  Dorothee Schoemaker; Joseph F Arboleda-Velasquez
Journal:  Am J Pathol       Date:  2021-04-22       Impact factor: 4.307

9.  Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.

Authors:  Karen Horsburgh; Joanna M Wardlaw; Tom van Agtmael; Stuart M Allan; Mike L J Ashford; Philip M Bath; Rosalind Brown; Jason Berwick; M Zameel Cader; Roxana O Carare; John B Davis; Jessica Duncombe; Tracy D Farr; Jill H Fowler; Jozien Goense; Alessandra Granata; Catherine N Hall; Atticus H Hainsworth; Adam Harvey; Cheryl A Hawkes; Anne Joutel; Rajesh N Kalaria; Patrick G Kehoe; Catherine B Lawrence; Andy Lockhart; Seth Love; Malcolm R Macleod; I Mhairi Macrae; Hugh S Markus; Chris McCabe; Barry W McColl; Paul J Meakin; Alyson Miller; Maiken Nedergaard; Michael O'Sullivan; Terry J Quinn; Rikesh Rajani; Lisa M Saksida; Colin Smith; Kenneth J Smith; Rhian M Touyz; Rebecca C Trueman; Tao Wang; Anna Williams; Steven C R Williams; Lorraine M Work
Journal:  Clin Sci (Lond)       Date:  2018-04-30       Impact factor: 6.124

10.  MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease.

Authors:  Chaowu Liu; Deguang Yang; Hong Wang; Shengwei Hu; Xiaofei Xie; Li Zhang; Hongling Jia; Qi Qi
Journal:  Mol Cell Biochem       Date:  2021-08-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.